In the last 12 months, insiders at Pharvaris N.V. ($PHVS) filed 60 transactions with the SEC: 0 open-market purchases totaling $0 and 29 sales totaling $5,956,394. Net insider sentiment: net selling.
Pharvaris N.V. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Lesage Anne (Chief Early Development) — 22 transactions totaling $2,123,666
- Lu Peng (Chief Medical Officer) — 20 transactions totaling $1,323,571
- Schikan Johannes Gerardus Christiaan Petrus (Not found) — 5 transactions totaling $1,209,926
- Modig Berndt (Chief Executive Officer) — 4 transactions totaling $779,817
- Glassman Robert (Not found) — 4 transactions totaling $417,225
View all SEC Filings for Pharvaris N.V. (PHVS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Modig Berndt | Chief Executive Officer | S | Common Stock | 2292 | $29.22 | 137,500.0000 | 65,210,590 | 1.64% | 0.00% |
| May 15, 2026 | Souverijns Wim | Chief Commercial Officer | S | Common Stock | 10000 | $29.92 | 45,111.0000 | 65,210,590 | 18.15% | 0.02% |
| May 15, 2026 | Glassman Robert | Not found | M | Common Stock | 5333 | $22.31 | 20,500.0000 | 65,210,590 | 35.16% | 0.01% |
| May 15, 2026 | Glassman Robert | Not found | M | Stock Option (Right to Buy) | 5333 | $0.00 | 8,667.0000 | 65,210,590 | 38.09% | 0.01% |
| May 15, 2026 | Glassman Robert | Not found | S | Common Stock | 4667 | $29.82 | 10,500.0000 | 65,210,590 | 30.77% | 0.01% |
| May 15, 2026 | Glassman Robert | Not found | S | Common Stock | 5333 | $29.83 | 15,167.0000 | 65,210,590 | 26.01% | 0.01% |
| May 15, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | S | Common Stock | 8748 | $29.82 | 35,194.0000 | 65,210,590 | 19.91% | 0.01% |
| May 12, 2026 | Lu Peng | Chief Medical Officer | F | Common Stock | 117 | $29.95 | 65,857.0000 | 65,210,590 | 0.18% | 0.00% |
| May 11, 2026 | Lu Peng | Chief Medical Officer | F | Common Stock | 109 | $30.09 | 65,974.0000 | 65,210,590 | 0.16% | 0.00% |
| May 1, 2026 | Lu Peng | Chief Medical Officer | S | Common Stock | 14023 | $30.16 | 66,226.0000 | 65,210,590 | 17.47% | 0.02% |
| May 1, 2026 | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 143 | $0.00 | 205,308.0000 | 65,210,590 | 0.07% | 0.00% |
| May 1, 2026 | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 14023 | $0.00 | 205,451.0000 | 65,210,590 | 6.39% | 0.02% |
| May 1, 2026 | Lu Peng | Chief Medical Officer | S | Common Stock | 143 | $31.00 | 66,083.0000 | 65,210,590 | 0.22% | 0.00% |
| May 1, 2026 | Lu Peng | Chief Medical Officer | M | Common Stock | 14166 | $2.59 | 80,249.0000 | 65,210,590 | 21.44% | 0.02% |
| April 29, 2026 | Lesage Anne | Chief Early Development | M | Stock Option (Right to Buy) | 3700 | $0.00 | 12,772.0000 | 65,210,590 | 22.46% | 0.01% |
| April 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Not found | S | Common Stock | 3830 | $30.07 | 384,237.0000 | 65,210,590 | 0.99% | 0.01% |
| April 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Not found | S | Common Stock | 28400 | $30.30 | 355,837.0000 | 65,210,590 | 7.39% | 0.04% |
| April 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Not found | S | Common Stock | 670 | $31.03 | 355,167.0000 | 65,210,590 | 0.19% | 0.00% |
| April 29, 2026 | Lesage Anne | Chief Early Development | M | Common Stock | 3700 | $2.59 | 194,119.0000 | 65,210,590 | 1.94% | 0.01% |
| April 29, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 3700 | $30.08 | 190,419.0000 | 65,210,590 | 1.91% | 0.01% |
| April 30, 2026 | Lesage Anne | Chief Early Development | M | Common Stock | 3700 | $2.59 | 194,119.0000 | 65,210,590 | 1.94% | 0.01% |
| April 30, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 3700 | $30.26 | 190,419.0000 | 65,210,590 | 1.91% | 0.01% |
| April 30, 2026 | Lesage Anne | Chief Early Development | M | Common Stock | 18000 | $8.05 | 208,419.0000 | 65,210,590 | 9.45% | 0.03% |
| April 30, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 18000 | $30.26 | 190,419.0000 | 65,210,590 | 8.64% | 0.03% |
| April 29, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 3700 | $30.06 | 209,619.0000 | 65,210,590 | 1.73% | 0.01% |
| April 30, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 19200 | $30.26 | 190,419.0000 | 65,210,590 | 9.16% | 0.03% |
| April 30, 2026 | Lesage Anne | Chief Early Development | M | Stock Option (Right to Buy) | 3700 | $0.00 | 9,072.0000 | 65,210,590 | 28.97% | 0.01% |
| April 30, 2026 | Lesage Anne | Chief Early Development | M | Stock Option (Right to Buy) | 18000 | $0.00 | 82,000.0000 | 65,210,590 | 18.00% | 0.03% |
| April 29, 2026 | Lu Peng | Chief Medical Officer | M | Common Stock | 3733 | $2.59 | 69,816.0000 | 65,210,590 | 5.65% | 0.01% |
| April 29, 2026 | Lu Peng | Chief Medical Officer | S | Common Stock | 3733 | $30.06 | 62,350.0000 | 65,210,590 | 5.65% | 0.01% |
| April 30, 2026 | Lu Peng | Chief Medical Officer | M | Common Stock | 15000 | $2.59 | 81,083.0000 | 65,210,590 | 22.70% | 0.02% |
| April 30, 2026 | Lu Peng | Chief Medical Officer | S | Common Stock | 15000 | $30.24 | 66,083.0000 | 65,210,590 | 18.50% | 0.02% |
| April 29, 2026 | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 3733 | $0.00 | 234,474.0000 | 65,210,590 | 1.57% | 0.01% |
| April 30, 2026 | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 219,474.0000 | 65,210,590 | 6.40% | 0.02% |
| April 23, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 100 | $30.03 | 213,319.0000 | 65,210,590 | 0.05% | 0.00% |
| April 22, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 7000 | $30.05 | 213,319.0000 | 65,210,590 | 3.18% | 0.01% |
| April 22, 2026 | Lesage Anne | Chief Early Development | M | Common Stock | 7000 | $8.05 | 220,319.0000 | 65,210,590 | 3.28% | 0.01% |
| April 22, 2026 | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 7001 | $0.00 | 106,307.0000 | 65,210,590 | 6.18% | 0.01% |
| April 23, 2026 | Lu Peng | Chief Medical Officer | M | Stock Option (Right to Buy) | 100 | $0.00 | 106,207.0000 | 65,210,590 | 0.09% | 0.00% |
| April 22, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Not found | S | Common Stock | 7000 | $30.05 | 388,167.0000 | 65,210,590 | 1.77% | 0.01% |
| April 23, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Not found | S | Common Stock | 100 | $30.03 | 388,067.0000 | 65,210,590 | 0.03% | 0.00% |
| April 23, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 100 | $30.03 | 213,319.0000 | 65,210,590 | 0.05% | 0.00% |
| April 23, 2026 | Lesage Anne | Chief Early Development | M | Common Stock | 100 | $2.59 | 213,419.0000 | 65,210,590 | 0.05% | 0.00% |
| April 22, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 7000 | $30.05 | 213,419.0000 | 65,210,590 | 3.18% | 0.01% |
| April 22, 2026 | Lesage Anne | Chief Early Development | S | Common Stock | 500 | $30.00 | 213,319.0000 | 65,210,590 | 0.23% | 0.00% |
| April 22, 2026 | Lesage Anne | Chief Early Development | M | Common Stock | 500 | $2.59 | 213,819.0000 | 65,210,590 | 0.23% | 0.00% |
| April 22, 2026 | Lesage Anne | Chief Early Development | M | Stock Option (Right to Buy) | 500 | $0.00 | 15,972.0000 | 65,210,590 | 3.04% | 0.00% |
| April 22, 2026 | Lesage Anne | Chief Early Development | M | Stock Option (Right to Buy) | 7000 | $0.00 | 113,000.0000 | 65,210,590 | 5.83% | 0.01% |
| April 23, 2026 | Lesage Anne | Chief Early Development | M | Stock Option (Right to Buy) | 100 | $0.00 | 15,872.0000 | 65,210,590 | 0.63% | 0.00% |
| April 22, 2026 | Lu Peng | Chief Medical Officer | M | Common Stock | 7001 | $2.59 | 73,084.0000 | 65,210,590 | 10.59% | 0.01% |
| April 22, 2026 | Lu Peng | Chief Medical Officer | S | Common Stock | 7001 | $30.05 | 66,083.0000 | 65,210,590 | 9.58% | 0.01% |
| April 23, 2026 | Lu Peng | Chief Medical Officer | M | Common Stock | 100 | $2.59 | 66,183.0000 | 65,210,590 | 0.15% | 0.00% |
| April 23, 2026 | Lu Peng | Chief Medical Officer | S | Common Stock | 100 | $30.03 | 66,083.0000 | 65,210,590 | 0.15% | 0.00% |
| April 16, 2026 | Lu Peng | Chief Medical Officer | F | Common Stock | 226 | $28.78 | 66,083.0000 | 65,210,590 | 0.34% | 0.00% |
| April 16, 2026 | Modig Berndt | Chief Executive Officer | S | Common Stock | 2292 | $28.60 | 1,089,792.0000 | 65,210,590 | 0.21% | 0.00% |
| April 11, 2026 | Nijdam Anna | Principal Accounting Officer | F | Common Stock | 548 | $26.63 | 48,940.0000 | 65,210,590 | 1.11% | 0.00% |
| April 9, 2026 | Modig Berndt | Chief Executive Officer | S | Common Stock | 200 | $28.42 | 1,092,084.0000 | 65,210,590 | 0.02% | 0.00% |
| April 9, 2026 | Modig Berndt | Chief Executive Officer | S | Common Stock | 23133 | $27.74 | 1,092,284.0000 | 65,210,590 | 2.07% | 0.04% |
| April 6, 2026 | Nijdam Anna | Principal Accounting Officer | F | Common Stock | 1167 | $28.56 | 49,488.0000 | 65,210,590 | 2.30% | 0.00% |
| April 1, 2026 | Nijdam Anna | Principal Accounting Officer | F | Common Stock | 1164 | $28.25 | 50,655.0000 | 65,210,590 | 2.25% | 0.00% |